Dysferlin anticorps
-
- Antigène Voir toutes Dysferlin (DYSF) Anticorps
- Dysferlin (DYSF)
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Dysferlin est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
- Specificité
- This antibody detects endogenous levels of DP-1/TFDP1 protein (region surrounding Pro2013).
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen
- Pureté
- > 95 % pure by SDS-PAGE
- Top Product
- Discover our top product DYSF Anticorps primaire
-
-
- Indications d'application
-
ELISA: 1: 10000approx. 1: 20000. WB: 1: 500approx. 1: 1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Concentration
- 1.0 mg/mL
- Buffer
- Phosphate buffered saline (PBS), pH 7.2., 0.05 % Sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Antigène
- Dysferlin (DYSF)
- Autre désignation
- Dysferlin (DYSF Produits)
- Synonymes
- anticorps DYSF, anticorps fb73b05, anticorps wu:fb73b05, anticorps si:rp71-50c18.1, anticorps DKFZp459E1226, anticorps 2310004N10Rik, anticorps AI604795, anticorps D6Pas3, anticorps mFLJ00175, anticorps FER1L1, anticorps LGMD2B, anticorps MMD1, anticorps dysferlin, anticorps dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive), anticorps myoferlin, anticorps DYSF, anticorps dysf, anticorps LOC589501, anticorps Dysf
- Sujet
- Dysferlin is a muscle-specific protein that is essential for normal muscle function and development. Mutations in the human dysferlin gene, DYSF, which maps to chromosome 2p13.3-p13.1, are associated with limb girdle muscular dystrophy-2B (LGMD-2B) and a related, adult-onset, distal dystrophy known as Miyoshi myopathy (MM). Dysferlin, a protein with a molecular mass of approximately 230 kDa, localizes to the muscle fiber membrane, but is absent in MM and LGMD-2B muscle. Dysferlin is detected in 5-6 week embryos, when limbs begin to form regional differentiation. Although it is not essential for initial myogenesis, dysferlin appears to be critical for sustained normal function in mature muscle. It has been suggested that the absence of dysferlin during development gives rise to the disease phenotype in adulthood. Identical mutations in the dysferlin gene can produce more than one myopathy phenotype, indicating that additional genes and/or other factors are also involved in the clinical phenotype. The DYSF gene has no homology to any other known mammalian gene, but the protein product is related to the spermatogenesis factor fer-1 of Caenorhabditis elegans. The name 'dysferlin' combines the role of the gene in producing muscular dystrophy with its homology to C. elegans.Synonyms: DYSF, Dystrophy-associated fer-1-like protein, FER1L1, Fer-1-like protein 1
- Poids moléculaire
- approx. 240 kDa
- ID gène
- 8291
- NCBI Accession
- NP_001123927
- UniProt
- O75923
-